NDC 70661-007

LYPQOZET

(ezetimibe And Atorvastatin)

LYPQOZET is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Althera Pharmaceuticals, Llc. The primary component is Atorvastatin Calcium Trihydrate; Ezetimibe.

• Product ID: 70661-007_bd0e8df1-2810-4543-8600-ad6c45c399d6
• NDC: 70661-007
• Product Type: Human Prescription Drug
• Proprietary Name: LYPQOZET
• Generic Name: (ezetimibe And Atorvastatin)
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2021-01-14
• Marketing Category: ANDA /
• Application Number: ANDA206084
• Labeler Name: Althera Pharmaceuticals, LLC
• Substance Name: ATORVASTATIN CALCIUM TRIHYDRATE; EZETIMIBE
• Active Ingredient Strength: 41 mg/1; mg/1
• Pharm Classes: Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 70661-007-30

30 TABLET in 1 BOTTLE (70661-007-30)

• Marketing Start Date: 2021-01-14
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "LYPQOZET" or generic name "(ezetimibe And Atorvastatin)"

NDC	Brand Name	Generic Name
70661-005	LYPQOZET	(ezetimibe and atorvastatin)
70661-006	LYPQOZET	(ezetimibe and atorvastatin)
70661-007	LYPQOZET	(ezetimibe and atorvastatin)
70661-008	LYPQOZET	(ezetimibe and atorvastatin)